Immunotherapy and Targeted Therapy for Advanced Gastroesophageal Cancers — Proceedings from a Session Held Adjunct to the 2026 ASCO Gastrointestinal Cancers Symposium

Featuring perspectives from Dr Jaffer A Ajani, Dr Samuel J Klempner, Dr Rutika Mehta and Dr John Strickler, moderated by Dr Klempner, including the following topics:

• Introduction (0:00)
• HER2-Targeted Approaches for Advanced Gastroesophageal Cancers — Dr Ajani (2:02)
• Faculty Panel Discussion: Cases and Questions from the Community (14:13)
• Targeting Claudin 18.2 in Advanced Gastroesophageal Cancers — Dr Strickler (37:29)
• Faculty Panel Discussion: Cases and Questions from the Community (49:21)
• Optimal Incorporation of Immunotherapeutic Strategies into Treatment for Patients with Metastatic Gastroesophageal Tumors — Dr Mehta (1:09:56)
• Faculty Panel Discussion: Cases and Questions from the Community (1:22:02)
• Other Novel Agents and Strategies Under Evaluation for Advanced Gastroesophageal Cancers — Dr Klempner (1:44:23)

CME information and select publications